Trial
NCT01543269
A Clinical Study to Evaluate the Safety,Tolerability and PK of ZYT1, Following Oral Administration in Healthy Volunteers
Phase ITERMINATEDSAFETYConfidence: MEDIUM
Sponsor
Zydus Lifesciences Limited
Collaborators
—
Condition
Obesity
Intervention
ZYT1
Why stopped
Safety concerns
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2015-11-24